Andrew Cheng

Andrew Cheng

Chief Executive Officer at AKERO THERAPEUTICS, INC.

Net worth: 9 M $ as of 2024-04-29

57 year
Health Technology
Consumer Services
Commercial Services

Profile

Andrew Cheng is currently the President, Chief Executive Officer & Director at Akero Therapeutics, Inc. He is also a Non-Executive Director at MorphoSys AG and an Independent Director at Vera Therapeutics, Inc. Additionally, he serves as a Director at Boys & Girls Clubs of Metro Los Angeles.
Previously, he held the position of Independent Director at Arbutus Biopharma Corp.
from 2019 to 2022.
He also served as a Director at Syntimmune, Inc. and Global Virus Network.
Prior to that, he was the Chief Medical Officer & Executive Vice President at Gilead Sciences, Inc. from 1999 to 2018.
Dr. Cheng obtained his doctorate degree from Columbia University College of Physicians & Surgeons in 1996.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-04-01 461,914 ( 0.67% ) 9 M $ 2024-04-29
2024-05-14 17,488 ( 0.03% ) 676 611 $ 2024-04-29

Andrew Cheng active positions

CompaniesPositionStart
AKERO THERAPEUTICS, INC. Chief Executive Officer 2018-08-31
VERA THERAPEUTICS, INC. Director/Board Member 2017-04-30
MORPHOSYS AG Director/Board Member 2022-05-17
Director/Board Member -
All active positions of Andrew Cheng

Former positions of Andrew Cheng

CompaniesPositionEnd
ARBUTUS BIOPHARMA CORPORATION Director/Board Member 2022-05-24
GILEAD SCIENCES, INC. Chief Tech/Sci/R&D Officer 2018-09-06
Director/Board Member -
Director/Board Member -
See the detail of Andrew Cheng's experience

Training of Andrew Cheng

The Johns Hopkins University Undergraduate Degree
Columbia University College of Physicians & Surgeons Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Andrew Cheng's experience

Connections

100 +

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies5
GILEAD SCIENCES, INC.

Health Technology

AKERO THERAPEUTICS, INC.

Health Technology

ARBUTUS BIOPHARMA CORPORATION

Health Technology

VERA THERAPEUTICS, INC.

Health Technology

MORPHOSYS AG

Health Technology

Private companies3

Commercial Services

Health Technology

Commercial Services

See company connections